Mabuza J Mcebisi, Kaiser Marcel, Bapela M Johanna
University of Pretoria, Department of Plant and Soil Sciences, Hatfield, 0028, South Africa; University of Pretoria Institute for Sustainable Malaria Control and Medical Research Council Collaborating Center for Malaria Research, South Africa.
Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.
J Ethnopharmacol. 2022 Nov 15;298:115659. doi: 10.1016/j.jep.2022.115659. Epub 2022 Aug 28.
The Vha-Venda people of South Africa use Pappea capensis EckI & Zeyh. (Sapindaceae) twigs to treat malaria and its related symptoms.
The main aim of this study was to evaluate the antiplasmodial and cytotoxic activity of P. capensis extracts and chromatographic fractions. Spectroscopy analysis was conducted using H NMR and GC-MS to tentatively identify the major classes of compounds and phytoconstituents that can be attributed to the observed antiplasmodial bioactivity.
Pappea capensis twigs were dried and then ground to fine powder. A solvent mixture of dichloromethane: methanol: water (1:0.5:0.5, v/v) was used to extract. The polar extract was separated from the non-polar. The organic extract was dried to yield a DCM (I = 60 g) extract. The methanol in the aqueous extract was evaporated using a rotary vapour and the remaining water freeze dried to yield a water extract (II = 287 g). Extract I was further partitioned using a solvent mixture of DCM: MeOH (1:1, v/v), separated and concentrated under vacuum to yield dichloromethane (III = 40 g) and methanol (IV = 15 g) extracts. A water-based decoction (V = 10 g) was also prepared to establish the clinical relevance of the preparation administered by Vha-Venda people in South Africa. Extracts II, III and IV were further subjected to silica column chromatography, eluting with a series of different solvents with increasing polarity to yield a total of 25 fractions (A - Y). In vitro antiplasmodial tests on Plasmodium falciparum (NF54) and cytotoxicity screens on mammalian L-6 rat skeletal myoblast cells were performed on all extracts and fractions. Selectivity indices (SI) were also computed for all tested extracts and fractions which were further subjected to H NMR spectroscopy and GC-MS analysis for the identification of the major classes of compounds present in the extracts.
From the assayed extracts, only extract I (IC = 2.93 μg/ml; SI = 14), III (IC = 2.59 μg/ml; SI = 21) and IV (IC = 3.56 μg/ml; SI = 13) demonstrated the best antiplasmodial activity and selectivity. Of all assayed fractions, only N (0.6 μg/ml; SI = 91), D (0.85 μg/ml; SI = 37) and E (0.91 μg/ml; SI = 30) depicted the best antiplasmodial activity and selectivity. The H NMR analysis of the extracts and fractions identified the prominent class of constituents to be aliphatic based which was tentatively identified as terpenoids. When further GC-MS analysis was conducted, the presence of lupin-3-one, lupeol acetate, α-amyrin, and β-amyrin phytoconstituents were tentatively confirmed. These constituents are triterpenoids with established antiplasmodial activity which can be tentatively attributed to the bioactivity observed in P. capensis twigs.
The study validates the ethnomedicinal use of P. capensis for malaria treatment. It demonstrated the potential of discovering novel antiplasmodial constituents that could serve as drug hits through dereplication approaches where known compounds with established antimalarial activity can be bypassed to focus on the unknown.
南非的万丹人使用南非无患子(无患子科)的树枝来治疗疟疾及其相关症状。
本研究的主要目的是评估南非无患子提取物和色谱馏分的抗疟活性和细胞毒性。使用核磁共振氢谱(¹H NMR)和气相色谱 - 质谱联用(GC - MS)进行光谱分析,以初步鉴定可归因于所观察到的抗疟生物活性的主要化合物类别和植物成分。
将南非无患子树枝干燥后研磨成细粉。使用二氯甲烷:甲醇:水(1:0.5:0.5,v/v)的溶剂混合物进行提取。将极性提取物与非极性提取物分离。有机提取物干燥后得到二氯甲烷提取物(I = 60 g)。水提取物中的甲醇使用旋转蒸发仪蒸发,剩余的水冷冻干燥得到水提取物(II = 287 g)。提取物I进一步用二氯甲烷:甲醇(1:1,v/v)的溶剂混合物进行分配,分离并在真空下浓缩,得到二氯甲烷提取物(III = 40 g)和甲醇提取物(IV = 15 g)。还制备了水基煎剂(V = 10 g),以确定南非万丹人所使用制剂的临床相关性。提取物II、III和IV进一步进行硅胶柱色谱分离,用一系列极性递增的不同溶剂洗脱,共得到25个馏分(A - Y)。对所有提取物和馏分进行了针对恶性疟原虫(NF54)的体外抗疟试验以及对哺乳动物L - 6大鼠骨骼肌成肌细胞的细胞毒性筛选。还计算了所有测试提取物和馏分的选择性指数(SI),并对其进一步进行¹H NMR光谱和GC - MS分析,以鉴定提取物中存在的主要化合物类别。
在所测定的提取物中,只有提取物I(半数抑制浓度[IC₅₀] = 2.93 μg/ml;选择性指数[SI] = 14)、III(IC₅₀ = 2.59 μg/ml;SI = 21)和IV(IC₅₀ = 3.56 μg/ml;SI = 13)表现出最佳的抗疟活性和选择性。在所有测定的馏分中,只有N(0.6 μg/ml;SI = 91)、D(0.85 μg/ml;SI = 37)和E(0.91 μg/ml;SI = 30)表现出最佳的抗疟活性和选择性。对提取物和馏分的¹H NMR分析确定主要成分类别为基于脂肪族的,初步鉴定为萜类化合物。进一步进行GC - MS分析时,初步确认存在羽扇豆 - 3 - 酮、乙酸羽扇豆醇酯、α - 香树脂醇和β - 香树脂醇等植物成分。这些成分是具有已确定抗疟活性的三萜类化合物,可初步归因于在南非无患子树枝中观察到的生物活性。
该研究验证了南非无患子在疟疾治疗中的民族药用价值。它展示了通过去重复方法发现新型抗疟成分的潜力,即可以绕过已知具有抗疟活性的化合物,专注于未知化合物,从而有可能发现可作为药物先导物的新型抗疟成分。